Ms. Kristin Comella is a world renowned expert on regenerative medicine with a focus on adipose derived stem cells. She was named number 24 on Terrapin’s list of the Top 50 Global Stem Cell Influencers and number 1 on the Academy of Regenerative Practices list of Top 10 Stem Cell Innovators. Ms. Comella has pioneered stem cell therapies from various sources including cord blood, bone marrow, muscle, and adipose tissue. She lead the team that gained the first ever FDA approval for a clinical trial using a combined cell and gene therapy product in the heart. In addition to advanced cell culturing experience, Ms. Comella’s repertoire includes managing the development, manufacturing, and quality systems of cellular products. She has developed a wide range of regenerative techniques and products that have now been successfully implemented into the clinic setting.
As Stem Cell therapy finds its way into Doctors’ offices, one will undoubtedly see inferior products entering the market. We have done our homework and finally decided to partner with the oldest regenerative group in America, US Stemcell Inc.
US Stemcell Inc. (previously known as Bio Heart Inc.) is the world leader in providing innovative treatment and management of patients with severe cardiovascular and peripheral vascular disease. They are also focused on the discovery, development and commercialization of autologous cell therapies for the treatment of degenerative diseases.
We are proud to be in partnership with such a reputable group whose standards meet the highest criteria in this demanding field.
Our staff received personal training from Kristin Comella and a complete transfer of current and future intellectual property, which will strengthen the hand of both parties. Thus we will be able to expand our services and deliver even more types of cell therapies in the future.